US Stock MarketDetailed Quotes

NRXP NRX Pharmaceuticals

Watchlist
  • 1.7100
  • -0.0100-0.58%
Close Sep 16 16:00 ET
  • 1.6700
  • -0.0400-2.34%
Post 18:08 ET
18.38MMarket Cap-638P/E (TTM)

NRX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
67.20%-2.56M
39.71%-3.67M
45.52%-21.66M
61.63%-3.19M
27.16%-4.56M
47.18%-7.81M
41.34%-6.09M
-5.44%-39.76M
26.26%-8.32M
47.84%-6.27M
Net income from continuing operations
9.41%-7.9M
40.86%-6.53M
24.16%-30.15M
57.70%-4.33M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
57.28%-39.75M
66.32%-10.24M
75.48%-9.08M
Operating gains losses
-263.64%-18K
175.00%9K
92.16%-20K
136.84%7K
-170.27%-26K
109.48%11K
92.36%-12K
85.93%-255K
97.81%-19K
-99.78%37K
Depreciation and amortization
0.00%1K
0.00%1K
25.00%5K
0.00%1K
100.00%2K
0.00%1K
0.00%1K
100.00%4K
--1K
0.00%1K
Other non cash items
141.84%2.21M
-82.05%318K
172.53%2.96M
-117.23%-87K
--359K
136.80%913K
184.34%1.77M
-107.51%-4.08M
-97.39%505K
--0
Change In working capital
640.25%3.05M
-8.30%2.29M
638.77%5.16M
261.49%2.42M
-63.72%812K
90.90%-564K
-37.51%2.49M
114.27%699K
171.43%670K
259.86%2.24M
-Change in prepaid assets
-308.35%-898K
-49.08%250K
581.01%3.04M
83.23%1.49M
-51.90%632K
109.61%431K
-71.57%491K
86.86%-632K
-34.65%811K
209.41%1.31M
-Change in payables and accrued expense
496.48%3.95M
1.70%2.04M
59.58%2.12M
763.83%936K
-80.52%180K
42.02%-995K
-11.53%2M
244.67%1.33M
93.53%-141K
564.32%924K
Cash from discontinued investing activities
Operating cash flow
67.20%-2.56M
39.71%-3.67M
45.52%-21.66M
61.63%-3.19M
27.16%-4.56M
47.18%-7.81M
41.34%-6.09M
-5.44%-39.76M
26.26%-8.32M
47.84%-6.27M
Investing cash flow
Cash flow from continuing investing activities
0
0
70.00%-3K
0.00%1K
60.00%-2K
166.67%2K
-33.33%-4K
-42.86%-10K
1K
-25.00%-5K
Net PPE purchase and sale
--0
--0
70.00%-3K
0.00%1K
60.00%-2K
166.67%2K
-33.33%-4K
-42.86%-10K
--1K
-25.00%-5K
Cash from discontinued investing activities
Investing cash flow
--0
--0
70.00%-3K
0.00%1K
60.00%-2K
166.67%2K
-33.33%-4K
-42.86%-10K
--1K
-25.00%-5K
Financing cash flow
Cash flow from continuing financing activities
-49.93%3.14M
-84.48%395K
-80.75%6.2M
-111.03%-1.12M
-5,260.71%-1.5M
829.42%6.27M
-88.93%2.55M
-49.23%32.21M
1,012,100.00%10.12M
-100.07%-28K
Net issuance payments of debt
-100.14%-1K
---2.16M
-132.54%-3.09M
-111.14%-1.12M
---2.67M
--696K
--0
844.67%9.5M
1,001,900.00%10.02M
--0
Net common stock issuance
-43.66%3.14M
0.20%2.55M
-64.22%8.12M
--0
--0
1,730.70%5.58M
-88.93%2.55M
-38.62%22.7M
--92K
-100.10%-28K
Net preferred stock issuance
----
----
--1.17M
--0
----
----
----
--0
--0
----
Proceeds from stock option exercised by employees
----
----
--0
----
----
----
----
-99.94%10K
----
----
Cash from discontinued financing activities
Financing cash flow
-49.93%3.14M
-84.48%395K
-80.75%6.2M
-111.03%-1.12M
-5,260.71%-1.5M
829.42%6.27M
-88.93%2.55M
-49.23%32.21M
1,012,100.00%10.12M
-100.07%-28K
Net cash flow
Beginning cash position
-92.01%1.32M
-77.09%4.6M
-27.35%20.05M
-51.22%8.9M
-39.02%14.97M
-58.94%16.51M
-27.35%20.05M
1,384.94%27.61M
-53.07%18.25M
83.39%24.55M
Current changes in cash
137.67%579K
7.67%-3.28M
-104.73%-15.46M
-338.61%-4.31M
3.68%-6.07M
90.18%-1.54M
-128.17%-3.55M
-129.33%-7.55M
116.00%1.81M
-124.70%-6.3M
End cash Position
-87.32%1.9M
-92.01%1.32M
-77.09%4.6M
-77.09%4.6M
-51.22%8.9M
-39.02%14.97M
-58.94%16.51M
-27.35%20.05M
-27.35%20.05M
-53.07%18.25M
Free cash flow
67.20%-2.56M
39.75%-3.67M
45.53%-21.66M
61.63%-3.19M
27.19%-4.57M
47.21%-7.81M
41.32%-6.09M
-5.45%-39.77M
26.27%-8.32M
47.82%-6.27M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 67.20%-2.56M39.71%-3.67M45.52%-21.66M61.63%-3.19M27.16%-4.56M47.18%-7.81M41.34%-6.09M-5.44%-39.76M26.26%-8.32M47.84%-6.27M
Net income from continuing operations 9.41%-7.9M40.86%-6.53M24.16%-30.15M57.70%-4.33M33.26%-6.06M-24.85%-8.72M17.91%-11.04M57.28%-39.75M66.32%-10.24M75.48%-9.08M
Operating gains losses -263.64%-18K175.00%9K92.16%-20K136.84%7K-170.27%-26K109.48%11K92.36%-12K85.93%-255K97.81%-19K-99.78%37K
Depreciation and amortization 0.00%1K0.00%1K25.00%5K0.00%1K100.00%2K0.00%1K0.00%1K100.00%4K--1K0.00%1K
Other non cash items 141.84%2.21M-82.05%318K172.53%2.96M-117.23%-87K--359K136.80%913K184.34%1.77M-107.51%-4.08M-97.39%505K--0
Change In working capital 640.25%3.05M-8.30%2.29M638.77%5.16M261.49%2.42M-63.72%812K90.90%-564K-37.51%2.49M114.27%699K171.43%670K259.86%2.24M
-Change in prepaid assets -308.35%-898K-49.08%250K581.01%3.04M83.23%1.49M-51.90%632K109.61%431K-71.57%491K86.86%-632K-34.65%811K209.41%1.31M
-Change in payables and accrued expense 496.48%3.95M1.70%2.04M59.58%2.12M763.83%936K-80.52%180K42.02%-995K-11.53%2M244.67%1.33M93.53%-141K564.32%924K
Cash from discontinued investing activities
Operating cash flow 67.20%-2.56M39.71%-3.67M45.52%-21.66M61.63%-3.19M27.16%-4.56M47.18%-7.81M41.34%-6.09M-5.44%-39.76M26.26%-8.32M47.84%-6.27M
Investing cash flow
Cash flow from continuing investing activities 0070.00%-3K0.00%1K60.00%-2K166.67%2K-33.33%-4K-42.86%-10K1K-25.00%-5K
Net PPE purchase and sale --0--070.00%-3K0.00%1K60.00%-2K166.67%2K-33.33%-4K-42.86%-10K--1K-25.00%-5K
Cash from discontinued investing activities
Investing cash flow --0--070.00%-3K0.00%1K60.00%-2K166.67%2K-33.33%-4K-42.86%-10K--1K-25.00%-5K
Financing cash flow
Cash flow from continuing financing activities -49.93%3.14M-84.48%395K-80.75%6.2M-111.03%-1.12M-5,260.71%-1.5M829.42%6.27M-88.93%2.55M-49.23%32.21M1,012,100.00%10.12M-100.07%-28K
Net issuance payments of debt -100.14%-1K---2.16M-132.54%-3.09M-111.14%-1.12M---2.67M--696K--0844.67%9.5M1,001,900.00%10.02M--0
Net common stock issuance -43.66%3.14M0.20%2.55M-64.22%8.12M--0--01,730.70%5.58M-88.93%2.55M-38.62%22.7M--92K-100.10%-28K
Net preferred stock issuance ----------1.17M--0--------------0--0----
Proceeds from stock option exercised by employees ----------0-----------------99.94%10K--------
Cash from discontinued financing activities
Financing cash flow -49.93%3.14M-84.48%395K-80.75%6.2M-111.03%-1.12M-5,260.71%-1.5M829.42%6.27M-88.93%2.55M-49.23%32.21M1,012,100.00%10.12M-100.07%-28K
Net cash flow
Beginning cash position -92.01%1.32M-77.09%4.6M-27.35%20.05M-51.22%8.9M-39.02%14.97M-58.94%16.51M-27.35%20.05M1,384.94%27.61M-53.07%18.25M83.39%24.55M
Current changes in cash 137.67%579K7.67%-3.28M-104.73%-15.46M-338.61%-4.31M3.68%-6.07M90.18%-1.54M-128.17%-3.55M-129.33%-7.55M116.00%1.81M-124.70%-6.3M
End cash Position -87.32%1.9M-92.01%1.32M-77.09%4.6M-77.09%4.6M-51.22%8.9M-39.02%14.97M-58.94%16.51M-27.35%20.05M-27.35%20.05M-53.07%18.25M
Free cash flow 67.20%-2.56M39.75%-3.67M45.53%-21.66M61.63%-3.19M27.19%-4.57M47.21%-7.81M41.32%-6.09M-5.45%-39.77M26.27%-8.32M47.82%-6.27M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data